|
Tuesday, 06 June 2006 |
|
The following statement may be attributed to Sean Tipton, president, Coalition for the Advancement of Medical Research (CAMR): "The Coalition for the Advancement of Medical Research lauds Harvard University's announcement today that it will begin new research around somatic cell nuclear transfer (SCNT). |
|
|
Wednesday, 24 May 2006 |
|
Jackie Hunt Christensen, State Coordinator for Minnesota, spoke at a Stem Cell Rally on Capitol Hill today marking the anniversary of H.R. 810, the Stem Cell Research Enhancement Act, passing the House. |
|
|
Friday, 19 May 2006 |
|
On May 19th, 2006, Amy L. Comstock provided public witness testimony regarding Parkinson's research at the National Institutes of Health (NIH) before the U.S. Senate's Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies. |
|
|
Thursday, 18 May 2006 |
|
The Food and Drug Administration today approved Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson's disease. |
|
|
Tuesday, 16 May 2006 |
|
New Poll Results Show Growth in Overwhelming Support for Embryonic Stem Cell Research |
|
|
Tuesday, 16 May 2006 |
|
The Genetics Policy Institute presents the second annual "Stem Cell Policy and Advocacy Summit: Empowering the Pro-Cures Coalition." |
|
|
Thursday, 13 April 2006 |
NBC’s Dateline Features Parkinson’s Disease. Pull up a chair or set the TIVO for DATELINE on Sunday, April 16th at 7 pm (NBC), which will feature an hour-long show on Parkinson's disease
|
|
|
Tuesday, 07 March 2006 |
|
The Board of Directors, staff, and advocates of the Parkinson's Action Network express their sincere condolences to the friends and family of Dana Reeve, and to the Christopher Reeve Foundation. |
|
|
Thursday, 23 February 2006 |
|
PAN Scientific Advisor Dr. David Heydrick spoke with Maggie Fox of Reuters at the World Parkinson Congress in Washington, DC. |
|
|
Thursday, 23 February 2006 |
|
A National Institutes of Health-sponsored clinical trial with 200 Parkinson's disease patients has shown that creatine and minocycline may warrant further consideration for study in a large trial, according to Karl Kieburtz, M.D., M.P.H., University of Rochester, who spoke today at the World Parkinson Congress on behalf of the trial investigators. |
|
|
Tuesday, 14 February 2006 |
|
Sean Tipton was recently elected as the new president of the Coalition for the Advancement of Medical Research (CAMR), a non-profit group based in Washington, D.C. CAMR comprises nationally recognized health policy organizations, including the Parkinson's Action Network and the Association of American Medical Colleges, which interviewed him for their newsletter. |
|
|
<< Start < Prev 1 2 Next > End >>
|
| Results 16 - 26 of 26 |
Powered by Phase2 Technology